Innovation meets quality: moving cellular therapies at the National Institutes for Health from bench to bedside.
Where this comes from
- Record sourced from PubMed, PMID 15764029.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
The National Institutes of Health (NIH) Department of Transfusion Medicine has supported clinical investigation in cellular therapies over the past 20 years. This experience, which encompasses product development research, quality system design and product manufacturing for a wide range of early phase clinical trials, provides a firm basis for future work with novel stem cell therapies.
Medical subject headings
- National Institutes of Health (U.S.)
- Research